-+ 0.00%
-+ 0.00%
-+ 0.00%

GeneDx Holdings Affirms FY2026 Sales Guidance of $475.000M-$490.000M vs $482.324M Est

Benzinga·11/18/2026 13:33:47
Listen to the news
GeneDx Holdings (NASDAQ:WGS) affirms FY2026 sales outlook from $475.000 million-$490.000 million to $475.000 million-$490.000 million vs $482.324 million estimate.